The Prevalence of Frailty According to Kidney Function and Its Association with Cognitive Impairment, Nutritional Status, and Clinical Outcome

Overview

Journal BMC Nephrol

Publisher Biomed Central

Date 2025 Feb 10

PMID 39930363

Authors

Tae-Won Yang

YooMee Kang

Do-Hyung Kim

Young-Soo Kim

Oh-Young Kwon

Tae Won Lee

Dong Jun Park

Eunjin Bae

Affiliations

Soon will be listed here.

Abstract

Background: Frailty is a state of vulnerability to poor homeostatic resolution of after a stressful event. The prevalence of frailty in patients with chronic kidney disease (CKD) is more common than in the general population. Frailty is associated with a poor clinical prognosis, malnutrition, and cognitive impairment; however, studies on these factors in patients with CKD are lacking. Therefore, we aimed to evaluate the relationship between CKD and frailty, nutritional status, and cognitive impairment and their influence on clinical outcomes.

Methods: We prospectively enrolled participants from June 2019 to December 2020 and divided them into three CKD groups according to kidney function (CKD G1-2, CKD G3-4, and CKD G5D). Clinical outcomes were defined as the composite outcomes of all-cause death, hospitalization, and cardiovascular outcomes, including nonfatal myocardial infarction, revascularization, or stroke. To calculate the relative risk of frailty, cognitive impairment, nutritional status, and clinical outcome, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression analysis.

Result: A total of 83 patients were included, of whom 31.3% had frailty and 18.1% had cognitive impairment. In the CKD G5D group, the prevalence of frailty (56.7%, n = 17) was significantly higher, and the nutritional quotient score was lower in the other groups. The Korean-Montreal Cognitive Assessment score was significantly lower in the CKD G5D group; however, cognitive impairment did not differ among the three groups. Frailty was significantly associated with cognitive impairment and CKD G5D group. Cognitive impairment was significantly associated with older age and higher BMI. Well-nourished status was significantly associated with BMI and CKD G5D group. Patients in the CKD G5D group were significantly more likely to have adverse clinical outcomes.

Conclusions: The prevalence of frailty increased significantly as the CKD stage progressed. Particularly, CKD G5D group correlated with frailty and nutritional status, leading to poor clinical outcomes.

References

Shlipak M, Stehman-Breen C, Fried L, Song X, Siscovick D, Fried L . The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004; 43(5):861-7. DOI: 10.1053/j.ajkd.2003.12.049. View

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

Kulmala J, Nykanen I, Manty M, Hartikainen S . Association between frailty and dementia: a population-based study. Gerontology. 2013; 60(1):16-21. DOI: 10.1159/000353859. View

Levin A, Stevens P . Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2013; 85(1):49-61. DOI: 10.1038/ki.2013.444. View

McAdams-DeMarco M, Tan J, Salter M, Gross A, Meoni L, Jaar B . Frailty and Cognitive Function in Incident Hemodialysis Patients. Clin J Am Soc Nephrol. 2015; 10(12):2181-9. PMC: 4670760. DOI: 10.2215/CJN.01960215. View

Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani C . Sarcopenia in chronic kidney disease: what have we learned so far?. J Nephrol. 2020; 34(4):1347-1372. PMC: 8357704. DOI: 10.1007/s40620-020-00840-y. View

Corbi G, Cacciatore F, Komici K, Rengo G, Vitale D, Furgi G . Inter-relationships between Gender, Frailty and 10-Year Survival in Older Italian Adults: an observational longitudinal study. Sci Rep. 2019; 9(1):18416. PMC: 6895198. DOI: 10.1038/s41598-019-54897-2. View

Gupta J, Mitra N, Kanetsky P, Devaney J, Wing M, Reilly M . Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012; 7(12):1938-46. PMC: 3513744. DOI: 10.2215/CJN.03500412. View

Sugimoto T, Arai H, Sakurai T . An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr Gerontol Int. 2021; 22(2):99-109. DOI: 10.1111/ggi.14322. View

10.

Mansur H, Colugnati F, Grincenkov F, Bastos M . Frailty and quality of life: a cross-sectional study of Brazilian patients with pre-dialysis chronic kidney disease. Health Qual Life Outcomes. 2014; 12:27. PMC: 4234401. DOI: 10.1186/1477-7525-12-27. View

11.

Kopple J, Greene T, Chumlea W, Hollinger D, Maroni B, Merrill D . Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000; 57(4):1688-703. DOI: 10.1046/j.1523-1755.2000.00014.x. View

12.

Carrero J, Stenvinkel P, Cuppari L, Ikizler T, Kalantar-Zadeh K, Kaysen G . Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013; 23(2):77-90. DOI: 10.1053/j.jrn.2013.01.001. View

13.

Kim J, Kalantar-Zadeh K, Kopple J . Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2012; 24(3):337-51. DOI: 10.1681/ASN.2012010047. View

14.

Eyigor S, Kutsal Y, Duran E, Huner B, Paker N, Durmus B . Frailty prevalence and related factors in the older adult-FrailTURK Project. Age (Dordr). 2015; 37(3):9791. PMC: 4422824. DOI: 10.1007/s11357-015-9791-z. View

15.

Shinaberger C, Greenland S, Kopple J, Van Wyck D, Mehrotra R, Kovesdy C . Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr. 2008; 88(6):1511-8. PMC: 5500249. DOI: 10.3945/ajcn.2008.26665. View

16.

Johansen K, Chertow G, Jin C, Kutner N . Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007; 18(11):2960-7. DOI: 10.1681/ASN.2007020221. View

17.

Gale C, Cooper C, Sayer A . Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. Age Ageing. 2014; 44(1):162-5. PMC: 4311180. DOI: 10.1093/ageing/afu148. View

18.

Siriwardhana D, Hardoon S, Rait G, Weerasinghe M, Walters K . Prevalence of frailty and prefrailty among community-dwelling older adults in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2018; 8(3):e018195. PMC: 5855322. DOI: 10.1136/bmjopen-2017-018195. View

19.

Wilhelm-Leen E, Hall Y, Tamura M, Chertow G . Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med. 2009; 122(7):664-71.e2. PMC: 4117255. DOI: 10.1016/j.amjmed.2009.01.026. View

20.

Borges Bonan N, Schepers E, Pecoits-Filho R, Dhondt A, Pletinck A, De Somer F . Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease. Sci Rep. 2019; 9(1):10236. PMC: 6629661. DOI: 10.1038/s41598-019-46724-5. View